Purpose Most cases of cellulitis are traditionally attributed to b-hemolytic Streptococcus and Staphylococcus species, although in most cases, no organism is identified. Development of PCR using the conserved bacterial 16 S rRNA DNA permits identification of bacteria independent of conventional culture approaches and prior use of antibiotics. Methods We used PCR-based techniques to identify cellulitis etiology using aspirate samples from affected skin. Saline was infiltrated and aspirated at the site of greatest erythema or at the cellulitic border. Samples were tested for 16 S rRNA DNA, and organism-specific probes used to identify bacteria commonly seen in skin infections. Results Aspirates from 32 patients were studied, and 16 S rRNA DNA was detected in nine of these patient samples (28.1 %). Bacterial species were identified by PCR methods in six of these nine samples (66.6 %), with S. aureus and methicillin-resistant S. aureus (MRSA) identified in four and two, respectively, of these samples. Of the patients with positive aspirate bacterial cultures (3/9, 33.3 %), S. aureus and coagulase-negative Staphylococcus (CoNS) were present on cultures of two of the three (both 66.6 %) positive samples. Only in one of the three positive bacterial cultures did the PCR method detect the same organism as was detected by culture. Among patients with positive provider-collected clinical cultures, MRSA was the predominant organism (11/18, 61.1 %) and when present, it was found as the sole organism. Where S. aureus or Streptococcus species were detected by molecular methods, clinical cultures yielded a positive result as well. Conclusions PCR-based techniques do not appear to be more sensitive than aspirate cultures for the detection of pathogens in cellulitis.
Introduction
Cellulitis is a common inflammatory skin disorder, usually attributed to infection with Group A, b-hemolytic Streptococcus species and Staphylococcus aureus [1, 2] . Because of the recent increase in community-acquired methicillin-resistant S. aureus (CA-MRSA) skin and soft tissue infections [3, 4] , practice guidelines increasingly recommend treating uncomplicated cellulitis [5] with MRSA-effective regimens, leading to a greater use of nonbeta-lactam, broad-spectrum antibiotics [6] .
In most cases of cellulitis, an etiologic laboratory diagnosis is not aggressively pursued by physicians; furthermore \10 % cases eventually become bacteremic [7] . Previous approaches to defining the bacterial etiology of cellulitis used needle aspirates from the leading edge of the lesion for Gram stain and bacterial culture. The sensitivity of this approach is low, and it largely has been abandoned [1, [8] [9] [10] . We hypothesized that this low sensitivity was due to low bacterial loads or non-viable or lysed bacteria in the inflamed area and that new nucleic acid amplification techniques, such as the PCR, would be able to detect the causative bacteria from aspirates of the leading edge or site of maximal erythema.
Methods
We recruited and enrolled a systematic sample of adult patients whose admitting diagnosis was cellulitis, performed needle aspirates and evaluated the aspirates by PCR. Patients were identified within 24 h of admission. The protocol was approved by the Johns Hopkins Institutional Review Boards.
Exclusion criteria were an inability to provide informed consent, presence of a coagulopathy, hypotension or the presence of systemic inflammatory response syndrome (SIRS). The data collected included demographics, clinical and laboratory information, antimicrobial usage and hospital readmissions. Outcome measures were the predominant species identified by culture and/or PCR. A difference in the proportions of samples in terms of agreement between the results by PCR and provider culture versus those by aspirate culture and provider culture were evaluated using Fisher's exact test.
After informed consent, 3-5 mL of 0.85 % sterile nonbacteriostatic saline was infiltrated subcutaneously at the site of greatest erythema or at the cellulitic border using a 24-gauge needle. Clearly suppurative areas were avoided in patients with abscesses or wounds (13/32, 40.6 %). Fluid was aspirated and suspended in 0.5 mL of RNAlater Ò solution (Qiagen, Valencia, CA) or sterile saline. For negative controls, 0.25-0.5 mL of sterile saline was similarly infiltrated into and aspirated from an unaffected skin area on the forearm and suspended in 0.5 mL of RNAlater Ò solution or sterile saline. Samples were refrigerated at 4°C and subsequently frozen at -20°C until DNA extraction and PCR analysis. For comparison of clinical and PCR results, a random subset of cellulitis samples from nine patients were transported directly to the clinical laboratory within 30 min of collection, where they were processed using standard microbiological methods [11, 12] .
DNA was extracted from a 200-lL aliquot of the aspirate using the DNAeasy DNA Purification kit (Qiagen, Venlo, the Netherlands) according to the manufacturer's instructions. All reactions were performed in duplicate using the LightCycler 480 System (Roche Applied Science, Indianapolis, IN). Signals were considered positive if the amplification curve was 3 cycles below that of the negative control (approximately 35 cycles).
In samples where 16S rRNA DNA was detected, further analysis was performed for individual bacterial species identification, using primers and probes that have been previously described and validated in our laboratory [13] . The limit of detection varies according to the PCR assay and ranges from 10 1 to 10 2 CFU/mL. These samples were tested for the presence of: Streptococcus species (S. pyogenes and S. pneumoniae), Group B streptococci (GBS), Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli, Klebsiella oxytoca, K. pneumoniae, Morganella morganii, Proteus mirabilis, P. vulgaris, Pseudomonas aeruginosa, Enterococcus faecalis and Enterococcus faecium. All bacterial primers and probes were synthesized by TIB MOLBIOL (Adelphia, NJ).
Samples that were positive for 16S rRNA DNA but negative by these select primers for bacterial species identification were further analyzed using 16S rRNA sequencing. PCR reactions were carried out using SYBR green on the LightCycler system, and PCR products were separated by gel electrophoresis. DNA bands were excised from the gel and purified using the QIAquick Gel Extraction Kkt (Qiagen) and then sequenced by the Johns Hopkins Sequencing Center. The sequences were compared to known sequence libraries using the Blast program (http:// blast.ncbi.nlm.nih.gov/Blast.cgi).
Routine clinical bacterial cultures (aerobic culture only) were performed on provider-collected swabs for the identification of bacterial organisms from associated abscesses or wounds. However, clinical cultures were not available for all patients. Concurrent bacterial culture was performed on aspirates collected from nine of the recruited patients by directly inoculating 100 lL of aspirate onto sheep blood agar and chocolate agar plates. The agar plates were incubated at 35°C at 5-10 % CO 2 for 24 h; cultures negative for growth after 24 h were reincubated for an additional 24 h before finalized as negative for growth. Organisms were identified using routine clinical microbiology test procedures, including Gram stain, catalase, coagulase, oxidase, indole, and the API20E and API20NE test strips (bioMérieux, Marcy l'Etoile, France). Culture and organism identification were performed using standard clinical laboratory procedures and methods, as established in the clinical microbiology laboratory and guidelines of the Clinical and Laboratories Standards Institute (CLSI).
Results
Thirty-two patients were included in this study, and their baseline characteristics and characterization of their disease is described in Table 1 . More than half of patients had any history of prior cellulitis (59.4 %), including MRSA skin infections (31.3 %). Thirty-one (97 %) patients received antibiotics before sample collection, and the median time from first antibiotic administration to sample collection was 14 h (interquartile range 12.6-23.6). Provider-collected cultures were available for 100 % (13/13) of the patients with abscesses. Incision and drainage of abscesses was performed in nine of the 32 (28.1 %) patients; of these, eight (88.8 %) were positive for MRSA and one (11.1 %) was positive for viridians streptococci. Blood samples were collected for culture from 27 (84.3 %) subjects, of whom two (7.4 %) had a diagnosis of concurrent bacteremia [one patient with methicillin-sensitive S. aureus (MSSA) and one was diagnosed with S. pyogenes (Group A)].
We detected 16 S rRNA DNA in nine (28.1 %) patient samples, and bacterial species were identified by PCR methods in six (66.6 %) of these. For the other three positive samples, definitive organism identification was not achieved by either species-specific PCR or sequencing, as the signal detected by 16 S rRNA DNA PCR was too low to obtain a PCR product appropriate for sequencing. Of the two patients with bacteremia in association with cellulitis, the aspirate PCR was negative. PCR controls (collected from the forearm) were negative, with the exception of a single sample, which may represent contamination at the time of aspirate collection. Of note, this control was probe negative for the species tested in our panel of organisms.
S. aureus was the predominant organism identified by the PCR probe method. MRSA alone was present in two of the nine (22.2 %) samples, while MSSA was found in two samples, and once in combination with Alcaligenes faecalis (identified by sequencing). One sample was positive for E. coli and another single sample was positive for Streptococcus sp. (the probe does not distinguish between S. pneumoniae vs. S. pyogenes).
Of the nine aspirate cultures collected, three (33.3 %) were positive for bacterial organisms. S. aureus and CoNS were identified in two of these positive aspirate cultures; in both cases, S. aureus was detected by the PCR method. In the third positive aspirate sample culture, both CoNS and S. aureus were identified; however, only S. aureus was detected by the PCR method (the panel of PCR assays cannot detect CoNS.
The study results were compared to the corresponding clinical provider-obtained swab cultures (21 available patient samples; Table 2 ). The provider-collected swab cultures commonly reflect a more diverse bacterial flora, but 11 of the 18 (61.1 %) patient samples with any positive swab cultures had negative results by the 16S rRNA DNA PCR method. In those samples where S. aureus or Streptococcus sp. were detected by molecular methods, all of the clinical provider-collected swab cultures also yielded a positive result (Table 2) . For the 21 provider-collected swab samples, four corresponding aspirate cultures were available. Of those four samples, two had no growth by the aspirate culture, but were positive for MRSA and Corynebacterium sp., respectively, by the provider-collected sample. Two samples were positive for MRSA and MSSA, respectively, by both methods (Table 2 ). In summary, in five of the 21 (23.8 %) provider-collected swab cultures, probe identification matched the culture result, while two of the nine (22.2 %) aspirate cultures matched providercollected cultures (p = 1.0, Fisher's exact test).
Discussion
Our objective was to determine the bacterial etiologies of cellulitis by molecular methods compared to conventional culture methods and aspirate cultures. To the best of our IQR Inter-quartile range, SSTI skin and skin structure infection Unless stated otherwise, data are presented as the number (n) of patients, with the percentage (of 32 patients) given in parenthesis a Per exam or medical record b Blood from 27 of the 32 patients was cultured
Eubacterial PCR for the identification of the bacterial etiologies of cellulitis 539 knowledge, this is the first study to use 16 S rRNA DNA PCR analysis to study the bacterial etiology of cellulitis. Surprisingly, PCR did not substantially improve the frequency of bacterial detection, and our results are essentially no different from those of previous studies using traditional aspirate and biopsy cultures [2, 10, 14] . Since PCR can detect DNA from both viable and non-viable/ lysed organisms, it would be unlikely to be affected by recent antibiotic treatment. Therefore, our results further support the concept of low organism density in cellulitis, as previously described [8, 10, 15] . These negative results are of value in the context of the pathogenesis and management of cellulitis. Based on our study results together with those of previously published studies, we suggest that cellulitis-induced inflammation is likely due to the effects of bacterial toxins or other factors that diffuse into affected tissue via lymphatics or interstitial fluid, and that bacterial burden at the affected site is a less influential factor. The inflammatory cascade, once triggered, rather than the bacterial bio-burden, may largely define the pathogenesis of cellulitis. If so, we would propose that current treatment practices may need to be revised, in particular those that are based on vancomycin or broad-spectrum agents for which swab cultures are unobtainable or noncontributory.
There are some limitations to our study. As a limited set of species-specific probes was used, sequencing was necessary in some cases and ultimately restricted by the remaining sample quantity. Additionally, among PCRprobe-positive samples, mixed bacterial populations may have gone undetected, as these samples were not further sequenced to identify other, more unusual bacterial species not included in the probe set. Another potential limitation of the study was the absence of routine provider-collected and aspirate anaerobic cultures, and it is possible that this led to the lack of identification of anaerobic bacteria from the skin. Furthermore, since nearly all patients in our study received antibiotics prior to the collection of the wound specimens/samples, it was not possible to determine whether or to what extent the administration of antibiotics influenced our rate of organism recovery. However, this limitation is nearly unavoidable, as the determination of cellulitis remains a clinically guided diagnosis, and antibiotics are administered in the Emergency Department quickly in accordance with the current standard of care. Lastly, misclassification of conditions mimicking cellulitis (e.g., venous stasis dermatitis, vascular disease with dependent rubor, etc.) may have led to study case dilution and diminished the sensitivity of our approach.
In conclusion, our results emphasize the need for an improved understanding of the pathogenesis of cellulitis and its bacterial etiologies. Additional studies on the inflammatory mediators of cellulitis, including bacterial species-specific toxins, may help guide targeted therapy, limit the use of broad-spectrum antibiotics and could lead to new approaches in the treatment of cellulitis.
